Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1-Mutated Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer?

被引：1
|
作者：
Okeya, Aoba [1 ]
Shimomura, Akihiko [2 ]
Kitagawa, Dai [1 ]
Shimizu, Chikako [2 ]
机构：
[1] Natl Ctr Global Hlth & Med, Dept Breast Surg Oncol, Tokyo, Japan
[2] Natl Ctr Global Hlth & Med, Dept Breast & Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 28期
关键词：
ESR1; MUTATIONS;
D O I：
10.1200/JCO.24.00992
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
    Shah, Mirat
    Lingam, Hima
    Gao, Xin
    Gittleman, Haley
    Fiero, Mallorie H.
    Krol, Danielle
    Biel, Nikolett
    Ricks, Tiffany K.
    Fu, Wentao
    Hamed, Salaheldin
    Li, Fang
    Sun, Jillian
    Fan, Jianghong
    Schuck, Robert
    Grimstein, Manuela
    Tang, Liuya
    Kalavar, Shyam
    Abukhdeir, Abdelrahmman
    Pathak, Anand
    Ghosh, Soma
    Bulatao, Ilynn
    Tilley, Amy
    Pierce, William F.
    Mixter, Bronwyn D.
    Tang, Shenghui
    Pazdur, Richard
    Kluetz, Paul
    Amiri-Kordestani, Laleh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (10) : 1193 - 1201
  • [2] Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors
    Groheux, David
    Hatt, Mathieu
    Hindie, Elif
    Giacchetti, Sylvie
    de Cremoux, Patricia
    Lehmann-Che, Jacqueline
    Martineau, Antoine
    Marty, Michel
    Cuvier, Caroline
    Cheze-Le Rest, Catherine
    de Roquancourt, Anne
    Visvikis, Dimitris
    Espie, Marc
    CANCER, 2013, 119 (11) : 1960 - 1968
  • [3] Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer
    Rios-Hoyo, Alejandro
    Cobain, Erin
    Huppert, Laura A.
    Beitsch, Peter D.
    Buchholz, Thomas A.
    Esserman, Laura
    van't Veer, Laura J.
    Rugo, Hope S.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (22)
  • [4] Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
    Rugo, Hope S.
    Delord, Jean-Pierre
    Im, Seock-Ah
    Ott, Patrick A.
    Piha-Paul, Sarina A.
    Bedard, Philippe L.
    Sachdev, Jasgit
    Le Tourneau, Christophe
    van Brummelen, Emilie M. J.
    Varga, Andrea
    Salgado, Roberto
    Loi, Sherene
    Saraf, Sanatan
    Pietrangelo, Dina
    Karantza, Vassiliki
    Tan, Antoinette R.
    CLINICAL CANCER RESEARCH, 2018, 24 (12) : 2804 - 2811
  • [5] Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
    Cobain, Erin F.
    Hayes, Daniel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (32) : 3673 - +
  • [6] New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor-Positive Breast Cancer
    Pathak, Neha
    Oliveira, Mafalda
    ANNUAL REVIEW OF MEDICINE, 2025, 76 : 243 - 255
  • [7] Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
    Boer, Katalin
    ONCOTARGETS AND THERAPY, 2016, 9 : 6119 - 6125
  • [8] Dose-escalation study of SAR439859, an oral selective estrogen receptor degrader, in postmenopausal women with estrogen receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer
    Campone, Mario
    Bardia, Aditya
    Ulaner, Gary A.
    Chandarlapaty, Sarat
    Gosselin, Alice
    Doroumian, Severine
    Ming, Jeffrey
    Celanovic, Marina
    Linden, Hannah M.
    CANCER RESEARCH, 2020, 80 (04)
  • [9] Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status
    Yamashita, Hiroko
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (06): : 220 - 224
  • [10] Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer
    Honda, Chikako
    Kurozumi, Sasagu
    Katayama, Ayaka
    Hanna-Khalil, Bishoy
    Masuda, Kei
    Nakazawa, Yuko
    Ogino, Misato
    Obayashi, Sayaka
    Yajima, Reina
    Makiguchi, Takaya
    Oyama, Tetsunari
    Horiguchi, Jun
    Shirabe, Ken
    Fujii, Takaaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (06)
12345